Background: The clinical relevance of circulating tumor cell-white blood cell (CTC-WBC) clusters in cancer prognosis is a subject of ongoing debate. This study aims to unravel their contentious predictive value for patient outcomes.
Methods: We conducted a comprehensive literature search of PubMed, Embase, and Cochrane Library up to December 2022.